Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witten

Showing results (901-910 of 924) with videos related to

Pageof 93
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2024
Lewy body dementia: Overcoming barriers and identifying solutionsKanishka Agarwal, Wendi Backler, Ece Bayram, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Clinical and Translational Allergy|March 14, 2012
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergiesLaurian Zuidmeer-Jongejan, Montserrat Fernandez-Rivas, Lars K Poulsen, et al.
Blood Cancer Discovery|December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic VulnerabilitiesElisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
Elife|May 20, 2021
Standardized and reproducible measurement of decision-making in mice, Valeria Aguillon-Rodriguez, Dora Angelaki, et al.
Nature Communications|March 30, 2026
Mutant ribosomal protein RPS15 drives B cell malignancy through oxidative stress and genomic instabilityCatherine Gutierrez, Marwan Kwok, Neil Ruthen, et al.
International Archives of Allergy and Immunology|March 14, 2015
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergyLaurian Zuidmeer-Jongejan, Hans Huber, Ines Swoboda, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older AdultsNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
JAMA Internal Medicine|January 12, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical TrialAnne Bjerg Nielsen, Niklas Dyrby Johansen, Daniel Modin, et al.
Pageof 93

Showing results (901-910 of 924) with videos related to

Sort By:
Pageof 93
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 24, 2024
Lewy body dementia: Overcoming barriers and identifying solutionsKanishka Agarwal, Wendi Backler, Ece Bayram, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Clinical and Translational Allergy|March 14, 2012
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergiesLaurian Zuidmeer-Jongejan, Montserrat Fernandez-Rivas, Lars K Poulsen, et al.
Blood Cancer Discovery|December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic VulnerabilitiesElisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
Elife|May 20, 2021
Standardized and reproducible measurement of decision-making in mice, Valeria Aguillon-Rodriguez, Dora Angelaki, et al.
Nature Communications|March 30, 2026
Mutant ribosomal protein RPS15 drives B cell malignancy through oxidative stress and genomic instabilityCatherine Gutierrez, Marwan Kwok, Neil Ruthen, et al.
International Archives of Allergy and Immunology|March 14, 2015
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergyLaurian Zuidmeer-Jongejan, Hans Huber, Ines Swoboda, et al.
The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older AdultsNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.
JAMA Internal Medicine|January 12, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical TrialAnne Bjerg Nielsen, Niklas Dyrby Johansen, Daniel Modin, et al.
Pageof 93